Target N. V. Biotech is 10% Owner at Molecular Templates, Inc. (MTEM). They have made 31 open-market trades across 5 companies since 2017, most recently 2024-04-02.
CIK 0001259870
31 open-market purchases totalling $68.2M since 2017, never a sale. Across 31 scored buys the stock is down 1.4% at ninety days, and 7.3 points behind the S&P over the same stretch.
31 scored purchases · one row per filing · discretionary only
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 45% | 52% | 45% |
| Avg Move | -0.7% | +2.3% | -1.4% |
| Alpha | -1.4% | +0.2% | -7.3% |
| Scored | 31 | 31 | 31 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| MTEM | BUY | 2024-04-02 | 2024-04-04 | $2.35 | $588K | -16.2% | -17.2% | -39.9% |
| MGNX | BUY | 2023-09-07 | 2023-09-11 | $5.26 | $1.1M | -13.7% | -6.3% | +56.1% |
| MGNX | BUY | 2023-01-19 | 2023-01-23 | $5.30 | $795K | -2.0% | +8.4% | +10.9% |
| MGNX | BUY | 2022-11-22 | 2022-11-25 | $5.96 | $1.8M | +1.7% | -5.4% | +6.2% |
| MTEM | BUY | 2022-05-16 | 2022-05-18 | $1.18 | $236K | -11.0% | -24.3% | -17.8% |
| RDUS | BUY | 2022-01-05 | 2022-01-07 | $6.31 | $5.4M | -2.4% | +10.5% | +38.6% |
| MGNX | BUY | 2021-11-19 | 2021-11-23 | $18.50 | $3.7M | -10.2% | -6.7% | -45.5% |
| RDUS | BUY | 2021-09-29 | 2021-10-01 | $12.95 | $1.3M | +9.7% | +62.4% | -49.1% |
| RDUS | BUY | 2021-09-22 | 2021-09-24 | $12.28 | $1.8M | -4.5% | +68.4% | -44.0% |
| MTEM | BUY | 2021-09-16 | 2021-09-20 | $6.13 | $613K | +13.9% | +2.2% | -38.0% |
| MTEM | BUY | 2021-07-19 | 2021-07-21 | $7.02 | $2.6M | -6.0% | -11.4% | -19.7% |
| MGNX | BUY | 2021-06-21 | 2021-06-23 | $21.74 | $3.3M | +11.4% | +0.9% | -15.3% |
| MTEM | BUY | 2021-04-13 | 2021-04-15 | $8.23 | $3.3M | +3.5% | -5.3% | -21.3% |
| MTEM | BUY | 2021-04-07 | 2021-04-09 | $8.23 | $4.1M | +6.0% | +3.4% | -5.6% |
| MTEM | BUY | 2021-02-01 | 2021-02-03 | $11.69 | $935K | +4.2% | -15.5% | -30.8% |
| MTEM | BUY | 2021-01-29 | 2021-02-01 | $11.94 | $955K | +8.1% | -15.8% | -25.9% |
| MTEM | BUY | 2020-11-09 | 2020-11-12 | $9.11 | $1.5M | -13.8% | +0.7% | +25.6% |
| RDUS | BUY | 2020-11-05 | 2020-11-09 | $14.26 | $1.4M | +9.0% | -0.9% | +64.5% |
| ESPR | BUY | 2020-11-03 | 2020-11-04 | $25.31 | $5.1M | +11.0% | +11.4% | +27.3% |
| MTEM | BUY | 2020-10-28 | 2020-11-04 | $9.12 | $1.5M | -9.2% | -14.3% | +22.2% |
| RDUS | BUY | 2020-09-11 | 2020-09-14 | $11.33 | $4.5M | -10.6% | +8.9% | +20.6% |
| RDUS | BUY | 2020-07-08 | 2020-07-09 | $13.21 | $330K | -3.6% | -6.2% | -1.3% |
| RDUS | BUY | 2020-04-30 | 2020-05-04 | $15.75 | $788K | -14.9% | -15.1% | -17.7% |
| ESPR | BUY | 2019-07-23 | 2019-07-25 | $42.65 | $2.1M | -7.6% | -11.9% | -7.4% |
| ESPR | BUY | 2019-01-04 | 2019-01-07 | $41.29 | $3.3M | +2.9% | +9.1% | +0.8% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.